EN
EN FR ES

Barentz Announces Grand Opening of State-of-the-Art Pharmaceutical Development Center.

June 20, 2023

Mexico City, May 19, 2023 - Barentz, a global leading distributor of life science ingredients, is thrilled to announce the grand opening of its new, cutting-edge pharmaceutical development center. This state-of-the-art facility represents a significant milestone in our commitment to innovation and will serve as a collaboration hub for pharmaceutical and nutraceutical manufacturers in North America.

 

The new center, located in the heart of Mexico City, is designed to foster collaboration, inspire creativity, and drive formulation excellence to produce the most effective treatments for those who matter most: the patients. Additionally, our facility is fully equipped to offer technical support and training to our customers and suppliers.

 

“With the opening of this facility, Barentz is showing its commitment to the pharmaceutical and nutritional markets in not only Mexico but the broader N. American region. This will help reduce the time it takes for customers to develop and launch new products.  Barentz’ investment demonstrates our dedication to providing top-notch products and services.” Julio Rendon, Mexico Managing Director said.

 

“The inauguration of this site is a testament to Barentz’ commitment to become a global market leader in the pharmaceutical segment.  We are incredibly excited to invest in our commercial and technical teams who collaborate with our Principal partners to deliver value for the benefit of our customers every day” Mike McKenna, Barentz N. America CEO, said.

 

The new facility will focus on a range of key formulation areas, including formulation development & analytical characterization for both oral solids and liquid dosage forms. Our team of experts will work collaboratively to meet the evolving needs of the pharmaceutical industry. With their extensive knowledge and technical skills, they are prepared to enhance product formulations and provide a complete service to our customers. This includes suggesting suitable ingredients and assisting in the formulation and refinement of pharmaceutical products.

 

Barentz’s new pharmaceutical development center serves as a testament to our commitment to continues improvement and our entrepreneurial spirit. We are proud to say that our new pharmaceutical development center will allow us to continuous as your trusted partner in developing treatments that improve and save lives.

 

For more information about Barentz and the grand opening of our new pharmaceutical development center, please visit our website at: www.barentz.com

 

Barentz is a leading global life science ingredients distributor. The company sources branded specialty ingredients from leading manufacturers worldwide and its ingredient experts provide value-added technical support which includes pre-mixing, blending, ingredient formulation and ingredient testing from its state-of-the-art, customized formulation centers and application laboratories in EMEA, Americas and Asia-Pacific.

 

Established in 1953, Barentz has operations in more than 70 countries with a strong presence in Europe and North America, and a rapidly growing network in Latin America and Asia-Pacific. With a turnover of €2.5 billion, the company employs around 2,500 people worldwide and serves over 25,000 customers. For more information, visit: www.barentz-na.com.

 

Media Contacts:

 

Barentz

Jami Knoth

Marketing Manager, Barentz North America
1390 Jaycox Road
Avon, OH 44011
440-937-1000

jami.knoth@barentz.com